Investigative Gene Therapy for Canavan Disease has Been Given Three New Designations by the FDA
Myrtelle Inc. has just announced that they have been granted three new designations from the FDA for their investigative gene therapy called rAAV-Olig001-ASPA. This therapy is being investigated as a…